A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies. - Archive ouverte HAL Access content directly
Journal Articles Molecular Cancer Year : 2014

A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies.

(1) , (2) , (3) , (1) , (1)
1
2
3
Marine Pesson
  • Function : Author
  • PersonId : 951477
Pierre de La Grange
  • Function : Author
  • PersonId : 951464
Brigitte Simon
  • Function : Author
  • PersonId : 917308
Laurent Corcos
  • Function : Correspondent author
  • PersonId : 917311

Connectez-vous pour contacter l'auteur

Abstract

: Alternative pre-mRNA splicing (AS) widely expands proteome diversity through the combinatorial assembly of exons. The analysis of AS on a large scale, by using splice-sensitive microarrays, is a highly efficient method to detect the majority of known and predicted alternative transcripts for a given gene. The response to targeted anticancer therapies cannot easily be anticipated without prior knowledge of the expression, by the tumor, of target proteins or genes. To analyze, in depth, transcript structure and levels for genes involved in these responses, including AKT1-3, HER1-4, HIF1A, PIK3CA, PIK3R1-2, VEGFA-D and PIR, we engineered a dedicated gene chip with coverage of an average 185 probes per gene and, especially, exon-exon junction probes. As a proof of concept, we demonstrated the ability of such a chip to detect the effects of over-expressed SRSF2 RNA binding protein on the structure and abundance of mRNA products in H538 lung cancer cells conditionally over-expressing SRSF2. Major splicing changes were observed, including in HER1/EGFR pre-mRNA, which were also seen in human lung cancer samples over-expressing the SRSF2 protein. In addition, we showed that variations in HER1/EGFR pre-mRNA splicing triggered by SRSF2 overexpression in H358 cells resulted in a drop in HER1/EGFR protein level, which correlated with increased sensitivity to gefitinib, an EGFR tyrosine kinase inhibitor. We propose, therefore, that this novel tool could be especially relevant for clinical applications, with the aim to predict the response before treatment.
Fichier principal
Vignette du fichier
1476-4598-13-9.pdf (414.58 Ko) Télécharger le fichier
Vignette du fichier
1476-4598-13-9.xml (150.09 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Loading...

Dates and versions

inserm-00935318 , version 1 (23-01-2014)

Identifiers

Cite

Marine Pesson, Béatrice Eymin, Pierre de La Grange, Brigitte Simon, Laurent Corcos. A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies.. Molecular Cancer, 2014, 13 (1), pp.9. ⟨10.1186/1476-4598-13-9⟩. ⟨inserm-00935318⟩
616 View
197 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More